📰 Rom News
Page 674 - Rom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.
May 3, 2023
Ignacio Cerezo from UBS retains his positive opinion on the stock with a Buy rating. The target price remains unchanged at EUR 25.80. | May 3, 2023
May 3, 2023
Toby Ogg from JP Morgan retains his negative opinion on the stock with a Sell rating. The target price is unchanged at EUR 12. | May 3, 2023
May 3, 2023
According to ACI’s 2023 Prime Time for Real-Time report, transactions in the region are expected to grow from $675 million in 2022 to $2.6 billion by 2027, representing a CAGR of... | May 3, 2023
May 3, 2023
Already positive, the research from Goldman Sachs and its analyst Ben Andrews still consider the stock as a Buy opportunity. The target price continues to be set at GBX 13400. | May 3, 2023
May 3, 2023
Credit Suisse on Wednesday bumped up its estimate for peak Bank of England interest rates to 4.75% from 4.5%, citing recent upside surprises to growth, inflation and labour market data.... | May 3, 2023
May 3, 2023
In a research note, Credit Suisse analyst Trung Huynh has maintained his recommendation on the stock with a Buy rating. The target price is reduced from USD 50 to USD 47. | May 3, 2023
May 3, 2023
Stocks in London were called to open on Wednesday higher ahead of the US interest rate decision announcement, amid mostly positive updates from Londons large-cap companies. Market focus for... | May 3, 2023
May 3, 2023
Already positive, the research from Jefferies and its analyst Flora Bocahut still consider the stock as a Buy opportunity. The target price remains unchanged at EUR 89. | May 3, 2023
May 3, 2023
Press Release May 3 , 2023 ASUS Launches New 2023 Zenbook Global Brand Campaign Incredible Comes From Within Marine biologist... | May 3, 2023
May 3, 2023
Further data from study 014/015 of evenamide in treatment-resistant schizophrenia confirms potentially relevant role of glutamatergic release modification when added to TRS patients not responding... | May 3, 2023